Johns Hopkins ABX Guide
Kanamycin
Kanamycin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Short-term treatment of infections caused by E. coli, Proteus species (both indole-positive and indole-negative), Enterobacter aerogenes, Klebsiella pneumoniae, Serratia marcescens, Acinetobacter species.
- Note: other aminoglycosides including gentamicin, tobramycin, and/or amikacin are preferred in this setting.
- Staphylococcal infections (not drug of choice)
- Hepatic encephalopathy (oral formulation, no longer available in the U.S.)
- Bowel decontamination (oral formulation, no longer available in the U.S.)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of multi-drug resistant Mycobacterium tuberculosis (second line)
- Non-tubercular mycobacterial (NTM) infections
- Gonorrhea
- Urinary tract infections
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Short-term treatment of infections caused by E. coli, Proteus species (both indole-positive and indole-negative), Enterobacter aerogenes, Klebsiella pneumoniae, Serratia marcescens, Acinetobacter species.
- Note: other aminoglycosides including gentamicin, tobramycin, and/or amikacin are preferred in this setting.
- Staphylococcal infections (not drug of choice)
- Hepatic encephalopathy (oral formulation, no longer available in the U.S.)
- Bowel decontamination (oral formulation, no longer available in the U.S.)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of multi-drug resistant Mycobacterium tuberculosis (second line)
- Non-tubercular mycobacterial (NTM) infections
- Gonorrhea
- Urinary tract infections
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: September 30, 2018
Citation
Dzintars, Kathryn, and Paul A Pham. "Kanamycin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540299/0.0/Kanamycin.
Dzintars K, Pham PA. Kanamycin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540299/0.0/Kanamycin. Accessed October 3, 2022.
Dzintars, K., & Pham, P. A. (2018). Kanamycin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540299/0.0/Kanamycin
Dzintars K, Pham PA. Kanamycin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2022 October 03]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540299/0.0/Kanamycin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Kanamycin
ID - 540299
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/09/30/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540299/0.0/Kanamycin
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
